Global POCT Molecular Diagnostics Technology Supply, Demand and Key Producers, 2026-2032
Description
The global POCT Molecular Diagnostics Technology market size is expected to reach $ 12150 million by 2032, rising at a market growth of 9.4% CAGR during the forecast period (2026-2032).
Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation. At the same time, it can ensure the high specificity and sensitivity of the detection performance, making it suitable for a variety of inspection scenarios such as hospital emergency, primary medical units, families, customs, and sudden disaster sites.
The growth of the molecular POCT (point-of-care testing) diagnostics market is driven by a number of drivers. First, the global prevalence of infectious diseases and the growing problem of antibiotic resistance have increased the demand for rapid and accurate molecular diagnostics. Molecular POCT can quickly detect pathogens on site and provide reliable results, reducing waiting time and helping medical staff to be more efficient in infection control and treatment decisions. In addition, technological advances have improved the convenience and detection range of molecular POCT systems, promoting their widespread use in primary care institutions, emergency rooms and telemedicine to meet the needs of decentralized medical care.
However, the molecular POCT market still faces some limiting factors. High costs and technical complexity are barriers to promotion in many regions, especially in resource-poor developing markets. In addition, although molecular POCT can provide results quickly, its accuracy may not be as good as laboratory testing in complex pathological conditions, limiting its application in certain high-precision demand environments. Strict regulatory requirements are also a major challenge. The complex approval process for medical devices in various countries may extend the time to market and affect the expansion speed of the market.
In terms of international market share and ranking, the main manufacturers are Danaher (Cepe), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher, Bio-Tech, Bio-Bio, Shengxiang Bio, Cayoudi, Hangzhou Ustar, etc. In 2023, the top five manufacturers accounted for about 94% of the international market.
Molecular POCT (Point-of-Care Testing) diagnosis is showing a rapid growth trend in the global medical market. With the outbreak of the new crown epidemic, the demand for molecular POCT has been unprecedentedly promoted. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing the waiting time for testing and improving diagnostic efficiency. The increasing popularity of portable and rapid molecular testing equipment in primary care and remote areas has enabled high-precision molecular testing to be performed in places with insufficient medical resources. The development of such products has made the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improved public health.
As the molecular POCT market continues to expand, technological innovation is also accelerating. The application of emerging technologies such as nanomaterials, microfluidics, and CRISPR has promoted the miniaturization of molecular POCT devices and improved detection sensitivity, making the test results more accurate and faster. In addition, with the application of AI and the Internet of Things, the data management and analysis capabilities of molecular POCT devices have also been significantly enhanced, enabling them to be combined with telemedicine and cloud data sharing to bring more intelligent medical solutions. These technological advances have promoted the global application of molecular POCT, thereby improving the efficiency of disease prevention and public health management.
This report studies the global POCT Molecular Diagnostics Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for POCT Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of POCT Molecular Diagnostics Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global POCT Molecular Diagnostics Technology total market, 2021-2032, (USD Million)
Global POCT Molecular Diagnostics Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: POCT Molecular Diagnostics Technology total market, key domestic companies, and share, (USD Million)
Global POCT Molecular Diagnostics Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global POCT Molecular Diagnostics Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global POCT Molecular Diagnostics Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global POCT Molecular Diagnostics Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher (Cepheid), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bohui Innovation, AoBio, Shengxiang Bio, Kayoudi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world POCT Molecular Diagnostics Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global POCT Molecular Diagnostics Technology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global POCT Molecular Diagnostics Technology Market, Segmentation by Type:
Reagents Consumables
Equipment
Other
Global POCT Molecular Diagnostics Technology Market, Segmentation by Application:
Hospital
Decentralized Laboratory
Other
Companies Profiled:
Danaher (Cepheid)
Roche
Abbott
bioMérieux
Hologic
Thermo Fisher Scientific
Bohui Innovation
AoBio
Shengxiang Bio
Kayoudi
Hangzhou Yousda
Key Questions Answered
1. How big is the global POCT Molecular Diagnostics Technology market?
2. What is the demand of the global POCT Molecular Diagnostics Technology market?
3. What is the year over year growth of the global POCT Molecular Diagnostics Technology market?
4. What is the total value of the global POCT Molecular Diagnostics Technology market?
5. Who are the Major Players in the global POCT Molecular Diagnostics Technology market?
6. What are the growth factors driving the market demand?
Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation. At the same time, it can ensure the high specificity and sensitivity of the detection performance, making it suitable for a variety of inspection scenarios such as hospital emergency, primary medical units, families, customs, and sudden disaster sites.
The growth of the molecular POCT (point-of-care testing) diagnostics market is driven by a number of drivers. First, the global prevalence of infectious diseases and the growing problem of antibiotic resistance have increased the demand for rapid and accurate molecular diagnostics. Molecular POCT can quickly detect pathogens on site and provide reliable results, reducing waiting time and helping medical staff to be more efficient in infection control and treatment decisions. In addition, technological advances have improved the convenience and detection range of molecular POCT systems, promoting their widespread use in primary care institutions, emergency rooms and telemedicine to meet the needs of decentralized medical care.
However, the molecular POCT market still faces some limiting factors. High costs and technical complexity are barriers to promotion in many regions, especially in resource-poor developing markets. In addition, although molecular POCT can provide results quickly, its accuracy may not be as good as laboratory testing in complex pathological conditions, limiting its application in certain high-precision demand environments. Strict regulatory requirements are also a major challenge. The complex approval process for medical devices in various countries may extend the time to market and affect the expansion speed of the market.
In terms of international market share and ranking, the main manufacturers are Danaher (Cepe), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher, Bio-Tech, Bio-Bio, Shengxiang Bio, Cayoudi, Hangzhou Ustar, etc. In 2023, the top five manufacturers accounted for about 94% of the international market.
Molecular POCT (Point-of-Care Testing) diagnosis is showing a rapid growth trend in the global medical market. With the outbreak of the new crown epidemic, the demand for molecular POCT has been unprecedentedly promoted. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing the waiting time for testing and improving diagnostic efficiency. The increasing popularity of portable and rapid molecular testing equipment in primary care and remote areas has enabled high-precision molecular testing to be performed in places with insufficient medical resources. The development of such products has made the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improved public health.
As the molecular POCT market continues to expand, technological innovation is also accelerating. The application of emerging technologies such as nanomaterials, microfluidics, and CRISPR has promoted the miniaturization of molecular POCT devices and improved detection sensitivity, making the test results more accurate and faster. In addition, with the application of AI and the Internet of Things, the data management and analysis capabilities of molecular POCT devices have also been significantly enhanced, enabling them to be combined with telemedicine and cloud data sharing to bring more intelligent medical solutions. These technological advances have promoted the global application of molecular POCT, thereby improving the efficiency of disease prevention and public health management.
This report studies the global POCT Molecular Diagnostics Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for POCT Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of POCT Molecular Diagnostics Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global POCT Molecular Diagnostics Technology total market, 2021-2032, (USD Million)
Global POCT Molecular Diagnostics Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: POCT Molecular Diagnostics Technology total market, key domestic companies, and share, (USD Million)
Global POCT Molecular Diagnostics Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global POCT Molecular Diagnostics Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global POCT Molecular Diagnostics Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global POCT Molecular Diagnostics Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher (Cepheid), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bohui Innovation, AoBio, Shengxiang Bio, Kayoudi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world POCT Molecular Diagnostics Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global POCT Molecular Diagnostics Technology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global POCT Molecular Diagnostics Technology Market, Segmentation by Type:
Reagents Consumables
Equipment
Other
Global POCT Molecular Diagnostics Technology Market, Segmentation by Application:
Hospital
Decentralized Laboratory
Other
Companies Profiled:
Danaher (Cepheid)
Roche
Abbott
bioMérieux
Hologic
Thermo Fisher Scientific
Bohui Innovation
AoBio
Shengxiang Bio
Kayoudi
Hangzhou Yousda
Key Questions Answered
1. How big is the global POCT Molecular Diagnostics Technology market?
2. What is the demand of the global POCT Molecular Diagnostics Technology market?
3. What is the year over year growth of the global POCT Molecular Diagnostics Technology market?
4. What is the total value of the global POCT Molecular Diagnostics Technology market?
5. Who are the Major Players in the global POCT Molecular Diagnostics Technology market?
6. What are the growth factors driving the market demand?
Table of Contents
127 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World POCT Molecular Diagnostics Technology Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
